|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||10.95 - 11.24|
|52 Week Range||3.05 - 16.64|
|PE Ratio (TTM)||98.57|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Investors are clamoring for ways to get in on a popular, but risky, investing craze — marijuana! Despite the reality that pot is illegal under federal law, many states have legalized the substance and plenty of marijuana ETFs have cropped up as a result.
From poison pills to regulator involvement, the grass isn't necessarily greener on the other side for this pot stock.
With approximately 1,300 locations throughout Canada, this medical cannabis grower just greatly improved its exposure.
LEAMINGTON, ON, Dec. 4, 2017 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it has entered into an agreement to become a medical cannabis supplier to Shoppers Drug Mart. Subject to Health Canada's approval of Shoppers Drug Mart's application to be a licensed producer, under the terms of the agreement the Company will supply Shoppers Drug Mart with Aphria-branded medical cannabis products. It is expected the products will be sold online, as Canadian regulations currently restrict the sale of medical cannabis in retail pharmacies.
Toronto, Ontario--(Newsfile Corp. - December 4, 2017) - The following issues have been halted by IIROC: Company: Aphria Inc. TSX Symbol: APH (all issues) ...
Falling prices are usually good for consumers, but the possible reason behind this drop in pot prices is a double-edged sword for investors and consumers.
Categories: Yahoo FinanceAphria, Inc. relative valuation is OVERVALUED and it has a fundamental analysis score of 88. Our analysis is based on comparing Aphria, Inc. with the following peers – MediJane Holdings, Inc., Marijuana Company of America, Inc., LiveWire Ergogenics, Inc. and La Jolla Pharmaceutical Company (MJMD-US, MCOA-US, LVVV-US and LJPC-US). Aphria, Inc. has shown good performance ... Read more (Read more...)
LEAMINGTON, ON, Nov. 23, 2017 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) achieved another milestone as part of its expansion strategy, obtaining its Dealer's License pursuant to the Controlled Drugs and Substances Act under Health Canada. This permits the Company to possess, sell and transport medical cannabis oil and resin to international markets. "There is an incredible appetite for high-quality medical cannabis in legal markets around the world.
Aphria Achieves Next Milestone in International Expansion Strategy with Receipt of Dealer's License
Tokyo Smoke continues its ambitious national retail expansion by announcing that the Calgary, Alberta retail location will open Thurs., Dec. 7, marking the brand's first shop outside of Ontario. Tokyo ...
Marijuana stocks have become a big deal in both the U.S. and Canada as investors, producers and all the others stakeholders involved try to capture their little piece of what’s sure to become a massive industry. The New York Times had a big article Nov. 4 about the impending July 1, 2018 legalization of recreational marijuana use in Canada. “Proposing legislation to legalize the recreational use of marijuana was the easy part for Prime Minister Justin Trudeau,” wrote NYT author Ian Austen.
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Aphria, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)
Since the start of the year, the Canadian marijuana market has quietly exploded. The industry expanded from fewer than 10 publicly traded licensed producers to 23, all contributing to a total of 67. “It’s ...
LEAMINGTON, ON, Oct. 27, 2017 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH or USOTCQB: APHQF) is pleased to announce that Renah Persofsky and Shawn Dym were elected as new directors at the Company's annual general and special meeting held on October 25, 2017. Mr. Dym is a managing director at York Plains Investment Corp., a private investment vehicle focused on maximizing absolute returns by investing in a wide array of asset classes, including successful cannabis related investments. He currently serves on the board of advisors for Green Acre Capital, Canada's first private investment fund focused on the cannabis industry, as well as the board of directors at Wellpoint Health and Totally Green. "We are pleased to welcome Renah and Shawn to Aphria's Board of Directors. Together, they bring valuable capital markets and cannabis industry expertise that will be instrumental in driving Aphria's strategic direction as a global leader in the cannabis industry. Their passion for success in growing dynamic companies will be a tremendous asset to the board," said Vic Neufeld, Chief Executive Officer of Aphria.
Tokyo Smoke, an award-winning lifestyle brand that brings sophistication and design to the cannabis space, is pleased to confirm the final closing of its oversubscribed Series B funding of approximately ...
LEAMINGTON, ON, Oct. 24, 2017 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH or USOTCQB: APHQF), announced today that it completed its first shipment of cannabis oil to Australian medical life science company, Medlab Clinical Limited (ASX:MDC). The shipment is part of the previously announced agreement between Aphria and Medlab, in which Aphria will produce and supply high-yield cannabis extracts for Medlab to be used in its forthcoming human trial to test management of intractable pain in oncology patients – the first trial of its kind globally.